Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/jnis-2023-020868 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
How to Prevent Arrhythmias Following Acute Coronary Syndrome.
Clin Cardiol
January 2025
Second Department of Internal Medicine, University of Toyama, Toyama, Japan.
Multinational retrospective analysis of bridging therapy prior to chimeric antigen receptor t cells for relapsed/refractory acute lymphoblastic leukemia in children and young adults.
J Hematol Oncol
January 2025
Bavarian Cancer Research Center (BZKF), R/R ALL Study Group, Bavaria, Germany.
Anti-CD19 chimeric antigen receptor T cells (CAR) are a well-established treatment option for children and young adults suffering from relapsed/refractory B-lineage acute lymphoblastic leukemia. Bridging therapy is used to control disease prior to start of lymphodepletion before CAR infusion and thereby improve efficacy of CAR therapy. However, the effect of different bridging strategies on outcome, side effects and response to CAR therapy is still poorly understood.
View Article and Find Full Text PDFErgonomic challenges in surgical practice.
Surgeon
January 2025
Medical College of Wisconsin, Department of Surgery, Division of Trauma and Acute Care Surgery, Milwaukee, WI, USA. Electronic address:
Acute kidney injury post-endovascular therapy in stroke patients: systematic review insights.
J Neurointerv Surg
January 2025
Affiliated Hospital to Changchun University of Chinese Medicine, Changchun, Jilin, China
A novel KMT2A::DCP1A fusion gene in acute myeloid leukemia.
Leuk Res
January 2025
National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, PR China; Institute of Blood and Marrow Transplantation, Soochow University, Suzhou, PR China. Electronic address:
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!